In one paragraphArticle in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Annica R Stull-Lane *Department of Medical Microbiology and Immunology, University of California at Davis, Davis, California, USA.
Lizbeth Camacho *Department of Medical Microbiology and Immunology, University of California at Davis, Davis, California, USA.
Amber E R Van HeckeDepartment of Medical Microbiology and Immunology, University of California at Davis, Davis, California, USA.
Blanca Perez-SepulvedaInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, England, United Kingdom.
Eli J BejaranoDepartment of Medical Microbiology and Immunology, University of California at Davis, Davis, California, USA.
Maria G WinterDivision of Infectious Diseases, School of Medicine, University of California at Davis, Davis, California, USA.
Sebastian E WinterDivision of Infectious Diseases, School of Medicine, University of California at Davis, Davis, California, USA.ORCID 0000-0003-1532-9178 Jay C D HintonInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, England, United Kingdom.
Andreas J BäumlerDepartment of Medical Microbiology and Immunology, University of California at Davis, Davis, California, USA.ORCID 0000-0001-9152-7809 Hirotaka HiyoshiDepartment of Bacteriology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.ORCID 0000-0003-3709-2386 Renée M TsolisDepartment of Medical Microbiology and Immunology, University of California at Davis, Davis, California, USA.ORCID 0000-0001-9131-6657 Funding
Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Gina M Dayton · 2002 to 2026
$84.9MVirulence Factors of SalmonellaR01AI044170 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI BAUMLER, ANDREAS J · 1999 to 2022
$8.5MAnimal Models of Infectious Diseases Training ProgramT32AI060555 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI MCSORLEY, STEPHEN J · 2004 to 2025
$3.3MNeutrophil-intrinsic role of SLC11A1/NRAMP1 in control of bacterial infectionR01AI149632 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TSOLIS, RENEE M · 2019 to 2023
$2.4MPathogenesis of Salmonella bacteremiaR01AI098078 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TSOLIS, RENEE M · 2012 to 2016
$1.8MSalmonella pathogenicity island 2 triggers pore-induced intracellular trap formation to evade killing by neutrophilsR21AI143929 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HIYOSHI, HIROTAKA · 2020 to 2021
$432kPathogenesis of Salmonella BacteremiaR56AI098078 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TSOLIS, RENEE M · 2018 to 2018
$384kThe role of SLC11A1 in neutrophil antimicrobial responseF30AI143146 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI STULL-LANE, ANNICA · 2019 to 2023
$203kDaiichi Sankyo Foundation of Life ScienceJapan Society for the Promotion of Science JP21K07027, JP22KK0276, JP24K02280National Institute of Allergy and Infectious Diseases AI098078, AI149632National Institute of Allergy and Infectious Diseases AI143929National Institute of Allergy and Infectious Diseases F30AI143146National Institute of Allergy and Infectious Diseases T32AI060555NCI NIH HHS P30 CA093373NIAID NIH HHS F30 AI143146NIAID NIH HHS R01 AI044170NIAID NIH HHS R01 AI098078NIAID NIH HHS R01 AI149632NIAID NIH HHS R21 AI143929NIAID NIH HHS R56 AI098078NIAID NIH HHS T32 AI060555Takeda Science FoundationWellcome Trust
6 · The paper itselfAbstract
Indexed as
Bacterial ProteinsNeutrophilsReactive Oxygen SpeciesSalmonella typhimuriumAnimalsHumansImmune EvasionMiceRespiratory BurstSalmonella InfectionsBacterial ProteinsReactive Oxygen SpeciescomplementneutrophilsSalmonella
Identifiers
PMID40657912
PMCPMC12345174
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390